The American Society for Gastrointestinal Endoscopy recently released new clinical guidance on the screening for pancreatic cancer in people with genetic susceptibility (Gastrointest Endosc 2022 Feb 16. doi:10.1016/j.gie.2021.12.001). GEN’s Sarah Tilyou spoke with lead author Mandeep S. Sawhney, MD, MS, FASGE, a gastroenterologist at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School, in Boston, about the impetus for the guidelines and what they mean to GI practice.
Trending
- GI Grand Rounds lecture – GI 2.0: From Procedures to Pathways
- Gastroenterology Practice Economics: Benchmark 2026 (Jiro Health)
- Surgery Partners to be taken private by Bon Secours affiliate in $5.7 billion deal (Reuters)
- Guardant Health Applauds New Law Ensuring Access to Colorectal Cancer Screening Innovations with No Cost-Sharing for Pennsylvanians (Guardant Health)
- Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer (Genmab)
- Do Wearables in GI Care Provide Useful Data or Fuel Anxiety? (Medscape)
- APPs Poised to Level the Playing Field for Rural Patients With IBD (GI & Endoscopy News)
- Improve IBD bowel checks for early cancer detection, study finds (Eurekalert)
